{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:08:08Z","timestamp":1792325288351,"version":"4.4.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10,1]]},"DOI":"10.1093\/aje\/kwj254","type":"journal-article","created":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T23:33:24Z","timestamp":1152660804000},"page":"629-636","source":"Crossref","is-referenced-by-count":136,"title":["Risk of Brain Tumors Associated with Exposure to Exogenous Female Sex Hormones"],"prefix":"10.1093","volume":"164","author":[{"given":"Annette","family":"Wigertz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"L\u00f6nn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiit","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Ahlbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Feychting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"key":"key\n\t\t\t\t20171010151119_BIB1","unstructured":"Kleihues P, Cavenee WK. World Health Organization classification of tumours. Pathology and genetics: tumours of the nervous system. 2nd ed. Lyon, France: IARC Press, 2000."},{"key":"key\n\t\t\t\t20171010151119_BIB2","doi-asserted-by":"crossref","unstructured":"Inskip PD, Linet MS, Heineman EF. Etiology of brain tumors in adults. Epidemiol Rev1995;17:382\u2013414.","DOI":"10.1093\/oxfordjournals.epirev.a036200"},{"key":"key\n\t\t\t\t20171010151119_BIB3","doi-asserted-by":"crossref","unstructured":"Wrensch M, Minn Y, Chew T, et al. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncol2002;4:278\u201399.","DOI":"10.1215\/S152285170200011X"},{"key":"key\n\t\t\t\t20171010151119_BIB4","doi-asserted-by":"crossref","unstructured":"Ron E, Modan B, Boice JD Jr, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med1988;319:1033\u20139.","DOI":"10.1056\/NEJM198810203191601"},{"key":"key\n\t\t\t\t20171010151119_BIB5","doi-asserted-by":"crossref","unstructured":"Karlsson P, Holmberg E, Lundell M, et al. Intracranial tumors after exposure to ionizing radiation during infancy: a pooled analysis of two Swedish cohorts of 28,008 infants with skin hemangioma. Radiat Res1998;150:357\u201364.","DOI":"10.2307\/3579984"},{"key":"key\n\t\t\t\t20171010151119_BIB6","doi-asserted-by":"crossref","unstructured":"Preston DL, Ron E, Yonehara S, et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst2002;94:1555\u201363.","DOI":"10.1093\/jnci\/94.20.1555"},{"key":"key\n\t\t\t\t20171010151119_BIB7","doi-asserted-by":"crossref","unstructured":"Helseth A. Incidence and survival of intracranial meningioma patients in Norway 1963\u20131992. Neuroepidemiology1997;16:53\u20139.","DOI":"10.1159\/000109671"},{"key":"key\n\t\t\t\t20171010151119_BIB8","doi-asserted-by":"crossref","unstructured":"Klaeboe L, Lonn S, Scheie D, et al. Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968\u20131997. Int J Cancer2005;117:996\u20131001.","DOI":"10.1002\/ijc.21255"},{"key":"key\n\t\t\t\t20171010151119_BIB9","doi-asserted-by":"crossref","unstructured":"Bickerstaff ER, Small JM, Guest IA. The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry1958;21:89\u201391.","DOI":"10.1136\/jnnp.21.2.89"},{"key":"key\n\t\t\t\t20171010151119_BIB10","doi-asserted-by":"crossref","unstructured":"Michelsen JJ, New PF. Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry1969;32:305\u20137.","DOI":"10.1136\/jnnp.32.4.305"},{"key":"key\n\t\t\t\t20171010151119_BIB11","doi-asserted-by":"crossref","unstructured":"McKinley BP, Michalek AM, Fenstermaker RA, et al. The impact of age and sex on the incidence of glial tumors in New York State from 1976 to 1995. J Neurosurg2000;93:932\u20139.","DOI":"10.3171\/jns.2000.93.6.0932"},{"key":"key\n\t\t\t\t20171010151119_BIB12","doi-asserted-by":"crossref","unstructured":"Schoenberg BS, Christine BW, Whisnant JP. Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology1975;25:705\u201312.","DOI":"10.1212\/WNL.25.8.705"},{"key":"key\n\t\t\t\t20171010151119_BIB13","doi-asserted-by":"crossref","unstructured":"Custer BS, Koepsell TD, Mueller BA. The association between breast carcinoma and meningioma in women. Cancer2002;94:1626\u201335.","DOI":"10.1002\/cncr.10410"},{"key":"key\n\t\t\t\t20171010151119_BIB14","doi-asserted-by":"crossref","unstructured":"Sanson M, Cornu P. Biology of meningiomas. Acta Neurochir (Wien)2000;142:493\u2013505.","DOI":"10.1007\/s007010050462"},{"key":"key\n\t\t\t\t20171010151119_BIB15","doi-asserted-by":"crossref","unstructured":"Blankenstein MA, Verheijen FM, Jacobs JM, et al. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids2000;65:795\u2013800.","DOI":"10.1016\/S0039-128X(00)00193-8"},{"key":"key\n\t\t\t\t20171010151119_BIB16","doi-asserted-by":"crossref","unstructured":"Carroll RS, Zhang J, Dashner K, et al. Steroid hormone receptors in astrocytic neoplasms. Neurosurgery1995;37:496\u2013503.","DOI":"10.1097\/00006123-199509000-00019"},{"key":"key\n\t\t\t\t20171010151119_BIB17","doi-asserted-by":"crossref","unstructured":"Khalid H, Shibata S, Kishikawa M, et al. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors. Cancer1997;80:2133\u201340.","DOI":"10.1002\/(SICI)1097-0142(19971201)80:11<2133::AID-CNCR13>3.0.CO;2-#"},{"key":"key\n\t\t\t\t20171010151119_BIB18","unstructured":"Preston-Martin S, Monroe K, Lee PJ, et al. Spinal meningiomas in women in Los Angeles County: investigation of an etiological hypothesis. Cancer Epidemiol Biomarkers Prev1995;4:333\u20139."},{"key":"key\n\t\t\t\t20171010151119_BIB19","doi-asserted-by":"crossref","unstructured":"Schlehofer B, Blettner M, Preston-Martin S, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer1999;82:155\u201360.","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<155::AID-IJC1>3.0.CO;2-P"},{"key":"key\n\t\t\t\t20171010151119_BIB20","doi-asserted-by":"crossref","unstructured":"Jhawar BS, Fuchs CS, Colditz GA, et al. Sex steroid hormone exposures and risk for meningioma. J Neurosurg2003;99:848\u201353.","DOI":"10.3171\/jns.2003.99.5.0848"},{"key":"key\n\t\t\t\t20171010151119_BIB21","doi-asserted-by":"crossref","unstructured":"Huang K, Whelan EA, Ruder AM, et al. Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev2004;13:1583\u20138.","DOI":"10.1158\/1055-9965.1583.13.10"},{"key":"key\n\t\t\t\t20171010151119_BIB22","doi-asserted-by":"crossref","unstructured":"Hatch EE, Linet MS, Zhang J, et al. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer2005;114:797\u2013805.","DOI":"10.1002\/ijc.20776"},{"key":"key\n\t\t\t\t20171010151119_BIB23","doi-asserted-by":"crossref","unstructured":"Cardis E, Killkenny M. International case-control study of adult brain, head and neck tumours: results of the feasibility study. Radiat Protect Dosimetry1999;83:179\u201383.","DOI":"10.1093\/oxfordjournals.rpd.a032657"},{"key":"key\n\t\t\t\t20171010151119_BIB24","doi-asserted-by":"crossref","unstructured":"Poulter NR, Chang CL, Farley TM, et al. Reliability of data from proxy respondents in an international case-control study of cardiovascular disease and oral contraceptives. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. J Epidemiol Community Health1996;50:674\u201380.","DOI":"10.1136\/jech.50.6.674"},{"key":"key\n\t\t\t\t20171010151119_BIB25","doi-asserted-by":"crossref","unstructured":"Lonn S, Ahlbom A, Hall P, et al. Mobile phone use and the risk of acoustic neuroma. Epidemiology2004;15:653\u20139.","DOI":"10.1097\/01.ede.0000142519.00772.bf"},{"key":"key\n\t\t\t\t20171010151119_BIB26","doi-asserted-by":"crossref","unstructured":"Lonn S, Ahlbom A, Hall P, et al. Long-term mobile phone use and brain tumor risk. Am J Epidemiol2005;161:526\u201335.","DOI":"10.1093\/aje\/kwi091"},{"key":"key\n\t\t\t\t20171010151119_BIB27","unstructured":"SAS Institute, Inc. SAS statistical software. Cary, NC: SAS Institute, Inc, 2001."},{"key":"key\n\t\t\t\t20171010151119_BIB28","doi-asserted-by":"crossref","unstructured":"Dickson RB, Stancel GM. Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr2000(27):135\u201345.","DOI":"10.1093\/oxfordjournals.jncimonographs.a024237"},{"key":"key\n\t\t\t\t20171010151119_BIB29","doi-asserted-by":"crossref","unstructured":"Mulac-Jericevic B, Conneely OM. Reproductive tissue selective actions of progesterone receptors. Reproduction2004;128:139\u201346.","DOI":"10.1530\/rep.1.00189"},{"key":"key\n\t\t\t\t20171010151119_BIB30","doi-asserted-by":"crossref","unstructured":"Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA2002;288:321\u201333.","DOI":"10.1001\/jama.288.3.321"},{"key":"key\n\t\t\t\t20171010151119_BIB31","doi-asserted-by":"crossref","unstructured":"Lundgren CI, Hall P, Ekbom A, et al. Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer2003;106:569\u201373.","DOI":"10.1002\/ijc.11275"},{"key":"key\n\t\t\t\t20171010151119_BIB32","doi-asserted-by":"crossref","unstructured":"Matsuda Y, Kawamoto K, Kiya K, et al. Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg1994;80:527\u201334.","DOI":"10.3171\/jns.1994.80.3.0527"},{"key":"key\n\t\t\t\t20171010151119_BIB33","doi-asserted-by":"crossref","unstructured":"Grunberg SM, Weiss MH, Spitz IM, et al. Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg1991;74:861\u20136.","DOI":"10.3171\/jns.1991.74.6.0861"},{"key":"key\n\t\t\t\t20171010151119_BIB34","doi-asserted-by":"crossref","unstructured":"Lamberts SW, Tanghe HL, Avezaat CJ, et al. Mifepristone (RU 486) treatment of meningiomas. J Neurol Neurosurg Psychiatry1992;55:486\u201390.","DOI":"10.1136\/jnnp.55.6.486"},{"key":"key\n\t\t\t\t20171010151119_BIB35","doi-asserted-by":"crossref","unstructured":"Goodwin JW, Crowley J, Eyre HJ, et al. A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study. J Neurooncol1993;15:75\u20137.","DOI":"10.1007\/BF01050266"},{"key":"key\n\t\t\t\t20171010151119_BIB36","doi-asserted-by":"crossref","unstructured":"Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg1997;86:113\u201320.","DOI":"10.3171\/jns.1997.86.1.0113"},{"key":"key\n\t\t\t\t20171010151119_BIB37","doi-asserted-by":"crossref","unstructured":"Roser F, Nakamura M, Bellinzona M, et al. The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol2004;57:1033\u20137.","DOI":"10.1136\/jcp.2004.018333"},{"key":"key\n\t\t\t\t20171010151119_BIB38","doi-asserted-by":"crossref","unstructured":"Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol1984;23:305\u201313.","DOI":"10.3109\/02841868409136026"},{"key":"key\n\t\t\t\t20171010151119_BIB39","doi-asserted-by":"crossref","unstructured":"Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: The Women's Health Initiative Randomized Trial. JAMA2003;289:3243\u201353.","DOI":"10.1001\/jama.289.24.3243"},{"key":"key\n\t\t\t\t20171010151119_BIB40","doi-asserted-by":"crossref","unstructured":"Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet2003;362:419\u201327.","DOI":"10.1016\/S0140-6736(03)14065-2"},{"key":"key\n\t\t\t\t20171010151119_BIB41","doi-asserted-by":"crossref","unstructured":"Li CI, Malone KE, Porter PL, et al. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA2003;289:3254\u201363.","DOI":"10.1001\/jama.289.24.3254"},{"key":"key\n\t\t\t\t20171010151119_BIB42","doi-asserted-by":"crossref","unstructured":"Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA2004;291:1701\u201312.","DOI":"10.1001\/jama.291.14.1701"},{"key":"key\n\t\t\t\t20171010151119_BIB43","doi-asserted-by":"crossref","unstructured":"Finley C, Gregg EW, Solomon LJ, et al. Disparities in hormone replacement therapy use by socioeconomic status in a primary care population. J Community Health2001;26:39\u201350.","DOI":"10.1023\/A:1026537114638"},{"key":"key\n\t\t\t\t20171010151119_BIB44","doi-asserted-by":"crossref","unstructured":"Richiardi L, Boffetta P, Merletti F. Analysis of nonresponse bias in a population-based case-control study on lung cancer. J Clin Epidemiol2002;55:1033\u201340.","DOI":"10.1016\/S0895-4356(02)00455-9"},{"key":"key\n\t\t\t\t20171010151119_BIB45","doi-asserted-by":"crossref","unstructured":"Strom BL, Schinnar R. An interview strategy was critical for obtaining valid information on the use of hormone replacement therapy. J Clin Epidemiol2004;57:1210\u201313.","DOI":"10.1016\/j.jclinepi.2004.04.001"},{"key":"key\n\t\t\t\t20171010151119_BIB46","doi-asserted-by":"crossref","unstructured":"Norell SE, Boethius G, Persson I. Oral contraceptive use: interview data versus pharmacy records. Int J Epidemiol1998;27:1033\u20137.","DOI":"10.1093\/ije\/27.6.1033"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/164\/7\/629\/137622\/kwj254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T21:15:29Z","timestamp":1683494129000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/aje\/article\/164\/7\/629\/62812\/Risk-of-Brain-Tumors-Associated-with-Exposure-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,11]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2006,7,11]]},"published-print":{"date-parts":[[2006,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwj254","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,10,1]]},"published":{"date-parts":[[2006,7,11]]}}}